AD/PD 2026: AI-Driven Plasma Biomarkers for Neurodegenerative Disease

At the AD/PD 2026 Conference, Lijun An, PhD, Postdoctoral Fellow at Lund University, Sweden, discusses an AI-based analysis of plasma proteomics in nearly 20,000 participants. The model identifies potential biomarkers for neurodegenerative diseases like Parkinson’s disease and FTD and can predict cognitive decline years in advance. This approach highlights the potential of combining large-scale proteomic data with AI for early diagnosis and clinical decision-making.